| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | $2.19B | $1.83B | $1.29B | $1.36B | $1.44B |
| Operating Expenses | – | – | – | – | – |
| R&D | $261.13M | $246.61M | $322.22M | $306.84M | $188.49M |
| SG&A | $796.86M | $659.03M | $541.85M | $642.95M | $842.35M |
| Operating Income | $780.30M | $669.44M | -$1.97B | $121.16M | $21.31M |
| Interest Expense | $598.63M | $400.98M | $312.17M | $273.31M | $334.95M |
| Tax Expense | $557.51M | $234.23M | $114.37M | $133.46M | $111.41M |
| Net Income | -$251.84M | $183.20M | -$2.64B | -$775.95M | $500.10M |
| EPS (basic) | -0.1600 | 0.1100 | -2.9300 | -0.8700 | 0.5700 |
| EPS (diluted) | -0.1600 | 0.0200 | -2.9300 | -0.8700 | -0.3600 |
| Shares (diluted) | $1.61B | $1.74B | $901.14M | $886.82M | $911.59M |